Πέμπτη 23 Ιουνίου 2016

Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies

Conditions:   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Female Genital Organs;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Male Genital Organs
Interventions:   Drug: Alisertib;   Drug: TAK-228
Sponsors:   M.D. Anderson Cancer Center;   Millennium Pharmaceuticals, Inc.
Not yet recruiting - verified June 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/28QjhPj
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου